Economic Evaluation of the $35 Insulin Copay Cap Policy in Medicare and Its Implication for Future Interventions

Affiliations

• ¹ Center for Drug Evaluation and Safety, Department of Pharmaceutical Evaluation and Policy, University of Florida College of Pharmacy, Gainesville, FL.
• ² Department of Medicine and Pharmacology, School of Medicine, Tulane University, New Orleans, LA.
• ³ Department of Global Health Management and Policy, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA.
• ⁴ The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, Departments of Pharmacy, Health Services, and Economics, University of Washington, Seattle, WA.
• ⁵ Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI.
• ⁶ Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia.
• ⁷ Department of Family and Preventive Medicine, School of Medicine, Emory University, Atlanta, Georgia.